# FDA Inspection 1119195 - BioMarin Pharmaceutical Inc. - February 28, 2020

Source: https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/7e5e4d0c-38a8-4f92-bc27-edd0f409799a
Source feed: FDA_Inspections

> FDA Inspection 1119195 for BioMarin Pharmaceutical Inc. on February 28, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1119195
- Company Name: BioMarin Pharmaceutical Inc.
- Inspection Date: 2020-02-28
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1133648 - 2020-11-06](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/6e2da158-3b88-470e-8a76-7e65e3f46b16)
- [FDA Inspection 1046400 - 2017-12-07](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/ce564dc4-a4dd-4132-98b0-298f6df824e2)
- [FDA Inspection 867315 - 2014-02-17](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/379db746-d532-4b38-b556-03dfc3e92701)

Company: https://www.keypedia.com/companies/biomarin-pharmaceutical-inc/73126e34-fd3f-451a-beef-466225ecadc2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c